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Cysticercosis (CC) is a tissue infection caused by the larval cysts of the pork tapeworm Tae-
nia solium. It is usually acquired by eating contaminated food or drinking water. CC Cysts
can develop in the muscles, the eyes, the brain, and/or the spinal cord. T. solium is found
worldwide, but its prevalence has decreased in developed countries due to stricter meat
inspection and better hygiene and sanitation. Nevertheless, CC is still a leading cause of sei-
zures and epilepsy. In Spain, The disease is not nationally reportable and data on CC
infected animals are also missing, despite the European Directive 2003/99/EC.
Methodology/Principal findings
We performed a retrospective descriptive study using the Spanish Hospitalization Minimum
Data Set (CMBD). Data with ICD-9 CM cysticercosis code (“123.1”) placed in first or second
diagnostic position from 1997 to 2014 were analyzed. Hospitalization rates were calculated
and clinical characteristics were described. Spatial distribution of cases and their temporal
behavior were also assessed. A total of 1,912 hospital discharges with clinical cysticercosis
were identified. From 1998 to 2008, an increasing trend in the number of CC hospitalizations
was observed, decreasing afterwards, in parallel with a decrease in the external migration
rate. The Murcia region had the highest median hospitalization rate (13.37 hospitalizations/
100,000 population), followed by Navarra and Madrid. The 16–44 age group was the most
represented (63.6%). The three most frequent associated diagnoses were epilepsy and
convulsions (49.5%), hydrocephalus (11.8%) and encephalitis/myelitis/meningitis (11.6%).
Conclusions/Significance
There is a need for a common strategy on data collection, monitoring and reporting, which
would facilitate a more accurate picture on the CC epidemiological scenario. Even if most
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cases might be imported, improving the human and animal CC surveillance will result useful
both in gaining extended disease knowledge and reducing morbidity and related-costs.
Author summary
Cysticercosis (CC), caused by the larval cysts of the pork tapeworm Taenia solium, is a
neglected tropical disease (NTD). It is acquired when worm eggs are ingested and the
developing larvae migrate through the body and form cysts in tissues. Frequent in pigs, it
can also affect humans, usually when they swallow T. solium egg-contaminated soil, water
or food (mainly vegetables) or through self-infection or person to person transmission
when hygiene practices are insufficient. CC is the most frequent preventable cause of epi-
lepsy worldwide, and is estimated to cause 30% of all epilepsy cases in countries where the
parasite is endemic.T. solium in humans has been emerging as a public health concern in
Europe due to the increased number of diagnosed CC cases in recent decades. This situa-
tion has been linked to increased travels and migratory movements towards and from
endemic countries. In Spain, there is no surveillance system in place. Thus, the CC disease
burden remains unknown. This study provides an 18-year review of the epidemiological
trends and patient characteristics in order to assess the impact of CC hospitalizations in
Spain. In this way, we aimed to describe for the first time the national human CC scenario
in Spain.
Introduction
Cysticercosis (CC) is a parasitic tissue infection caused by larval cysts of the pork tapeworm
Taenia solium [1]. Pigs, the CC natural intermediate hosts, become infected by eating tape-
worm eggs in the feces of a human infected with a tapeworm. Human acquire CC through fae-
cal-oral contamination with T. solium eggs from human tapeworm carriers [2]. Humans are
the only definitive host for T. solium, while T. saginata CC is only a disease of cattle and has
veterinary importance in beef and dairy production [1,3].
Among foods, uncooked vegetables are the major source [3]. Clinical syndromes related to
CC are divided into neurocysticercosis and extraneural cysticercosis [2] [4]. Neurocysticerco-
sis (NCC) is the greatest cause of acquired epilepsy worldwide, and is also increasingly seen in
more developed countries because of immigration from endemic areas [2]. Other symptoms
of CC include intracranial hypertension, hydrocephalus, meningoencephalitis, psychiatric dis-
order, stroke, and/or radiculopathy or myelopathy, if the spinal cord is involved [5]. The peak
severity of CC has been estimated to occur 3–5 years after initial infection, but it can be
delayed over 30 years [6]. Outside the central nervous system, cysticercosis causes no major
symptoms besides the eye [2]. Postmortem studies in endemic areas suggest that 80% of NCC
infections are asymptomatic. Consequently, many cases are never diagnosed or are found inci-
dentally during imaging procedures [5].
Cysticercosis is a zoonosis of public health importance; with significant economic impacts
on the health and meat sectors. The prevalence of CC in humans is highly variable within a
country and between countries [1]. This variability is due to hygienic habits and socio-eco-
nomic conditions, quality of meat inspection and culinary habits. CC is common throughout
Latin America, most of Asia, sub-Saharan Africa, and parts of Oceania [7]. In Europe, human
CC is not notifiable and therefore it is difficult to assess its epidemiology. Detection and
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reporting of animal CC cases is mainly based on official meat inspection [8]. CC was consid-
ered to be endemic in the past, however, some foci continue to be reported in Bulgaria, Latvia,
Lithuania, Poland, Portugal, and Romania [9]. Sporadic cases of CC have also been docu-
mented in other EU countries, yet it is not known if transmission occurred recently or in the
past. An effective surveillance system is lacking at European level, so the problem may be cer-
tainly underestimated [10]. Besides, the increasing number of migrants from endemic coun-
tries (specially Latin America, Sub-Saharan Africa and Southeast Asia) and international
travelers has resulted in an increase of CC in Europe [11]. A particular epidemiological situa-
tion is present in Spain and Portugal, where a recent review carried out by Fabiani et al.
showed a number of cases more than fivefold the total cases reported in the seventeen Euro-
pean countries analyzed [10].
Spain is the country reporting the highest number of imported cases of CC, probably
because it hosts the largest number of migrants coming from Latin American in Europe [9],
where CC is highly prevalent [12]. Up to date, there is no surveillance system for CC disease
implemented in Spain. However, hospitalized cases are recorded within the National Health
System0s Hospital Discharge Records Database (Conjunto Mı́nimo Básico de Datos or CMBD
in Spanish) belonging to the Spanish Ministry of Health. In this paper, we describe for the first
time CC related hospitalizations in Spain between 1997 and 2014, in terms of time, geographi-
cal distribution, and disease related individual characteristics.
Methods
Data analysis
We performed a retrospective descriptive study using the CMBD for the time period January
1st, 1997 to December 31st, 2014. International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9CM), the ICD version employed during the study period, was
used for this purpose [13]. Registers with ICD-9 CM “other cestode infection” codes (“123.”)
placed in first or second diagnostic position were analyzed. For further analysis, hospitalization
discharges coded as cysticercosis (ICD-9 CM code 123.1) were selected.
The CMBD database receives notification from around 98% of the public hospitals in Spain
[14]. The National Health System (NHS) provides free medical care to 99.5% of the Spanish
population, although those persons not covered by the NHS can be attended at the public hos-
pitals. Private hospitals represent only a small proportion of all hospital admissions. Since
2005, CMBD also has a gradual coverage from private hospitals [15].
For each entry, we collected socio-demographic (sex, age and autonomous community of
residency) and clinical data (other diagnosis, type and department of admission, average
length of hospitalization, non-invasive procedures and history of surgical intervention during
the hospitalization, re-admission, outcome, hospitalization0s cost to the health care system,
financing regime and diagnosis related group (DRG)). Age was categorized in four groups:
0–15, 16–44, 45–64 and 65 years old. These four age categories were selected to provide an
overview of children, young adults, older adults and seniors. Other selected co-diagnoses were
also explored. These diagnoses were assessed by searching all those ICD-9-CM codes possibly
associated with CC in any diagnostic position, and included: diseases of the nervous system
and sense organs, endocrine, metabolic and immunity disorders and HIV infection. Differ-
ences in proportions were assessed by the χ2 test and 95% confidence intervals (95% CI) were
calculated. ANOVA was used to compare differences in means. We used two-sided tests and
p< 0.05 was considered significant.
The average number of hospitalizations per year and autonomous community (Comuni-
dades Autónomas or CC.AA in Spanish) were calculated in order to assess temporal and
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geographical patterns. Official population figures of the Spanish municipalities were used as
population at risk for the study period 1998–2014 [16]. Data was missing for 1997, thus the
population data from the Intercensus Population Estimates were used for that year [17].
Migrations Statistics were also obtained from the Spanish National Statistical Institute. The
external migration rates were computed by using residential variation statistic, only available
for the period 2002–2014 [18]. Those countries considered endemic for CC (Latin America,
Southeast Asia and Sub-Saharan Africa) were selected. External migration rates were com-
puted for the whole country and separately for those CC.AA with the highest CC hospitaliza-
tion rates. It was assumed that the age distribution of the population covered by these hospitals
was similar to the general population. Results in terms of mean rates by CC.AA were plotted in
maps for the whole study period using the Geographical Information System QGis free soft-
ware version 2.18.13. Data analysis was performed using STATA software version 12.
Ethics statement
This study involves the use of patient medical data from The Spanish Centralized Hospital Dis-
charge Database (CMBD). These data are hosted by the Ministry of Health Social Services and
Equality (Ministerio de Sanidad, Servicios Sociales e Igualdad or MSSSI in Spanish). Research-
ers working in public and private institutions can request the databases by filling, signing and
sending a questionnaire available at the MSSSI website. In this questionnaire a signed Confi-
dentiality Commitment is required. All data are anonymized and de-identified by the MSSSI
before it is provided to applicants. According to this Confidentiality Commitment signed with
the MSSSI, researchers cannot provide the data to other researchers that must request the data
directly to the MSSSI [14].
Results
Spatial and temporal trends in Spain
A total of 2,067 hospital discharges with “other cestode infection” diagnosis placed as first or
second diagnostic position were identified for the 18-year study period (ICD-9-CM codes
123.). Out of them, 1,912 cases (92,5%) were cysticercosis hospitalizations, while the remain-
ing 155 hospitalizations were due to intestinal taeniasis (Table 1).
The temporal distribution of hospitalizations related to clinical CC as first or second diag-
nosis during the 18-year study period is represented in Fig 1. From 1998 to 2008, an increasing
trend in the number of CC hospitalizations was observed. Hospitalization rates peaked in 2008
and were afterwards followed by a steady decline, in parallel with a decrease in the external
migration rate, which began to decline in 2006.
At national level, the median annual CC hospitalization rate was 4.22/100,000 population.
Regarding the regional distribution, the Murcia region had the highest median CC hospitaliza-
tion rate (13.37 hospitalizations/100,000 population), followed by Navarra (10.09/100,000 pop-
ulation), Madrid (9.32/100,000 population), Aragon (6.21/100,000 population) and Rioja
(6.04/100,000 population) (Fig 2, S1 Table).
Hospitalization trends from those regions with higher rates revealed different patterns. In
Murcia, hospitalization rate reached high values in 2005, 2008 and 2012, with an overall
decreasing trend. A similar trend was identified in Aragon, with peaks in 2004 and 2007 but a
tendency to increase since 2011. In Madrid and Navarra, the tendency in the number of hospi-
talization rates paralleled the external migration rate. In Rioja there was a peak between 2006
and 2008 (Fig 3).
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Clinical characteristics of cysticercosis related hospitalizations
The mean age of the 1,912 CC hospitalized patients was 38 years (range 0–97), being the 16–44
age group the most represented. This age group also had the highest incidence rate (6.3/
100,000), followed by above 65 years old (3.4/100,000), 45–64 years old (3.0/100,000) and
under 15 (2.2/100,000). The percentage of CC hospitalized men and women was similar. The
majority of patients were discharged at home, decease occurring in 1.5%. The average length
of stay for clinical CC hospitalizations was 13 days. We found a wide range for the hospitaliza-
tion median cost with a median per patient of 29,327.4 euros. Other clinical characteristics are
summarized in Table 2.
The most frequent diagnostics associated with clinical cysticercosis were diseases of the ner-
vous system and sense organs, such as epilepsy and convulsions (49.5%), hydrocephalus
(11.8%) encephalitis/myelitis/meningitis (11.6%) and occlusion of cerebral arteries/hemiplegia
(4.2%), which could be related to subarachnoideal NCC.
Of all hospitalizations with CC, surgical procedures in the central nervous system occurred
in 520 hospitalizations (27.2%). The most frequent were: diagnostic procedures on spinal cord
and spinal canal structures (n = 367), extracranial ventricular shunt and revision, removal, and
Table 1. Hospitalization discharges caused by intestinal and tissue Taenia spp (n = 2,067), CMBD database, 1997–2014, Spain.
Type of taeniasis ICD-9 codes ICD-9 description n %
Intestinal taeniasis 123.0 Taenia solium infection intestinal form 26 1.26
123.2 Taenia saginata infection 59 2.85
123.3 Taeniasis unspecified 70 3.39
Taenia solium cysticercosis 123.1 Cysticercosis 1,912 92.50
Total 2,067 100
https://doi.org/10.1371/journal.pntd.0006316.t001
Fig 1. Temporal trend of hospitalizations with cysticercosis as first or second diagnosis and external migration rates.
https://doi.org/10.1371/journal.pntd.0006316.g001
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irrigation of ventricular shunt (n = 169), procedures over the skull (craniotomy), brain, and
cerebral meninges (n = 30), and other neurosurgical procedures as ventriculostomy (n = 52).
Regarding other non-neurological diagnoses, the most frequent were unspecified essential
hypertension (9.1%), pure hypercholesterolemia (4.5%) and unspecified hyperlipidemia
(4.3%), diabetes mellitus (3.8%) and some addictions such as tobacco use disorder (8.7%) and
alcohol dependence syndrome (2.3%) (S2 Table).
Major diseases causing immunosuppression were checked in the database. Only 12 patients
were seropositive for the HIV and 3 presented disorders of the immune system causing immu-
nosuppression. Comparison of “immunosuppressed” and “immunocompetent” patients´ clin-
ical characteristics was carried out. The exitus outcome was more frequent in the
immunosuppressed group (6.7% vs 1.4%), although this difference was not significant
(p = 0.092). The only significant difference was related to the hospitalizations time; immuno-
suppressed patients were hospitalized longer than immunocompetent patients (p<0.001).
Discussion
This study provides an 18-year review of the epidemiological trends and patient characteristics
in order to assess the impact of CC hospitalizations in Spain. Overall, there were few intestinal
taeniases compared with clinical cysticercosis. Humans can become infected with taeniasis by
Fig 2. Clinical cysticercosis hospitalizations rates per 100,000 person-years by autonomous community, 1997–2014, Spain.
https://doi.org/10.1371/journal.pntd.0006316.g002
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eating raw or undercooked beef (T. saginata) or pork (T. solium and T. asiatica) [9]. This
lower rate would be explained because Taenia spp infections are mostly managed in outpatient
care, not requiring hospital admission. On the other hand, T. solium taeniasis could be overes-
timated since T. solium can be misidentified with the more common T. saginata [19]. Further-
more, prevalence of taeniosis is usually lower than that of CC, a fact understandable as one
tapeworm carrier may infect hundreds of people and thousands of pigs [20].
From 1998 to 2008, an increasing trend in the number of hospitalizations with CC was
observed, peaking in 2008 and steady declining afterwards, in parallel with a decrease in the
external migration rate. The analysis of the literature showed that due to increased migration
and travels from endemic regions, CC is becoming a constantly growing public health problem
also in high-income countries, particularly affecting communities where hygiene conditions
are poor and consequently the parasite’s eggs can spread [4,9,21]. In Spain, and probably
related to the economic crisis, many immigrants have return to their country of origin in the
last decade, which could contribute to explain the decrease in CC hospitalization rates, at least
Fig 3. Number of cysticercosis hospitalizations and external migration rates in those regions with higher rates.
https://doi.org/10.1371/journal.pntd.0006316.g003
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partially. Unfortunately, the data provided by the Spanish CMBD do not include the place of
origin of patients, so this hypothetical relationship is not sufficiently substantiated on data.
Autochthonous cases also exist in Europe, particularly in Spain and Portugal [10], but it seems
that the patients ‘profile differ. Esquivel et al. reported a growing frequency of CC in Madrid
(Spain), especially in young adults with active disease forms, which they related to changes in
migratory flows, as Spanish-born patients were elderly, had emigrated many years earlier from
rural areas where the disease was formerly prevalent, and had inactive forms of the disease
[22]. In our study, the most represented age group was 16–44 years old. This data might stand
the hypothesis on the supposed parallel between the number of (hospitalized) cases and the
migration trend (in particular that coming from Latin America). Nevertheless, further research
is needed to support this hypothesis.
On the other hand, immigration from endemic areas may also play a role in the appearance
of autochthonous CC by human to human transmission [2]. CC can be acquired through con-
sumption of food contaminated by a T. solium tapeworm–infected commercial food handler
from endemic countries, or even by direct contact [23]. Taenia eggs, which are infective shortly
after been excreted by hosts, have been recovered from the dirt under the fingernails as well as
from tapeworm carriers´ skin and clothes [24]. Moreover, tapeworm eggs can survive in con-
taminated produce for relatively long periods in the environment under favorable conditions
[25]. The recent small number of reported cases of autochthonous cysticercosis in the litera-
ture may indicate that the risk is low, however, misreporting of the disease and its long incuba-
tion period make difficult to assess this transmission pattern.
The 7.6% of clinical CC hospitalizations were pediatric cases (<15 years old). CC can occur
in children with only a single exposure to eggs. Children tend to have solitary cysts and fewer
complications [26]. In Europe, few pediatric CC have been reported, mainly in migrants from
Latin-America [9]. In Spain, a 13 years old autochthonous boy with focal seizure and previous
Table 2. Clinical characteristics of cysticercosis hospitalizations (n = 1,912), CMBD database, 1997–2014, Spain.
Variables n (%)
Sex Male 983 (51.4)
Female 929 (48.6)
Age-groups <15 y 145 (7.6)
16–44 y 1,216 (63.6)
45–64 y 308 (16.1)
> = 65 y 243 (12.7)
Surgical intervention No 1,690 (88.4)
Yes 222 (11.6)
Type of admission Urgent 1,558 (81.5)
Programmed 352 (18.4)
Others/unknown 2 (0.1)




Readmission No 1,707 (89.3)
Yes 205 (10.7)
Median (range)
Hospitalization time (days) 13.1 (0–205)
Hospitalization cost (euro) 29,327.4 (0–2,455,119.2)
https://doi.org/10.1371/journal.pntd.0006316.t002
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contact with CC infected Ecuadorian has been described [27]. Three more cases in non-Span-
ish born children have been described in the literature [28,29].
Murcia, Navarra and Madrid were the regions with the highest median hospitalization
rates. We know that in Spain, immigrants’ colonies tend to be concentrated within the national
territory, mainly in the regions of greater economic weight (Madrid, Catalonia and Valencian
community), with relevant differences by country of origin. According to official figures,
Madrid and Murcia are among the regions with the highest rates of Latin-American immigra-
tion [30]. However, these figures do not explain the case of Navarra. We also found significant
differences between regions. When we compare the hospitalization trends within the regions
with higher rates, with the external migration rates, only Madrid, Navarra and La Rioja corre-
lated, showing Murcia and Aragón independent patterns. A possible explanation might be the
higher proportion of autochthonous cases in these two regions, whether they are truly autoch-
thonous cases, or human to human transmitted. We know that Aragon has recently reinforced
the fight against animals’ diseases (2015) [31] and that transmission exist, as confirmed by a
recent teenager case in this same region (2017) [32]. Regarding the region of Murcia, it seems
that most CC are imported cases [33], even if the graphs didn´t overlapped perfectly. Other
possible explanations are differences in disease surveillance over the study period; differences
in the interest for cysticercosis from clinicians and researchers, or regional disparities on the
diagnostic criteria. Unfortunately, important information is missing in CMBD to settle further
hypotheses.
In regard to the signs and symptoms of clinical CC, they are particularly diverse and depend
upon several factors, such as the number, location, growth, stage of degeneration and inflam-
mation and host factors [34,35]. In this study, most frequent co-diagnoses were those affecting
the nervous system, being the most common seizures/epilepsy/convulsive symptoms, which is
consistent with the main associated symptoms to parenchymal CC [3]. Hydrocephalus,
encephalitis and meningitis were also common, as well as related medical procedures like ven-
triculostomy or extracranial ventricular shunt, mainly associated with subarachnoideal and
intraventricular CC. Overall, clinical CC symptoms are variable and depend on the types of
involvement and degree of inflammation, which in turn may depend on other factors, such as
the patient’s immune status, exposure time, etc. [35]. Immunosuppression has been linked to
the severity of the disease. In fact, the effect of the antiparasitic drug seems to occur by expos-
ing the parasites to the host’s immune system, rather than by a direct, immediate drug effect
on the parasite as a whole [36]. In this study, few patients presented any disorders of the
immune system or were seropositive for HIV. The influence of HIV infection on the natural
history of cysticercosis is yet to be defined [37]. Other frequent diagnoses were hyperlipidemia,
essential hypertension, tobacco use disorder and diabetes mellitus, although they were less
prevalent than in the general Spanish population [38]. Nevertheless, not all the patients´ diag-
noses and risk factors are recorded in the CMBD, only those considered by clinicians as related
to that hospitalization episode. Moreover, even if all the possible diagnoses were explored in
the database, there is important missing information in the CMBD regarding other basal
health conditions.
Limitations and conclusions
Several considerations should be taken into account when interpreting the findings from this
research. Our study included cases of CC requiring hospitalization (clinical CC), which is not
equivalent to the true CC incidence in the population. The CMBD provides information from
a network of hospitals that covers more than 99% of the population living in Spain [14], but it
does not include cases managed in outpatient settings or asymptomatic cases, thus CMBD is
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still underestimating the real burden of CC in Spain. Other relevant limitations in the CMBD
are: important individual data such as country of origin or possible related risk factors are
missing; information about laboratory test results are not recorded; and the CMBD do not
allow the follow-up of patients. Thus, further investigation is recommended.
The use of hospital records data for epidemiological consideration may also be prone to
imprecision due to the following reasons. The diagnosis of CC is complicated; imaging find-
ings are rarely pathognomonic and immunodiagnostic tests vary in sensitivity and specificity
[39]. Even if the diagnostic criteria have been agreed upon by international experts ‘consensus
[40–42], the standard diagnostic criteria in the daily clinical practice may differ.
Finally, at national (and also international) level, data on the animal side of the CC epidemi-
ological scenario are also missing. Despite the European Directive 2003/99/EC which recom-
mends monitoring animal CC according to the epidemiological situation [43], many countries
do not report these cases, including Spain [44]. There is a need for a common strategy on data
collection, monitoring and reporting, which would facilitate a more accurate picture on the
CC epidemiological situation. Even if the majority of cases are imported, improving the
human and animal CC surveillance will result useful both in gaining extended disease knowl-
edge and reducing morbidity and related-costs.
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